MERCURY LABORATORIES
Back to Balance Sheet
|
MERCURY LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1.89 Cr | ₹2.23 Cr | ₹2.13 Cr | ₹1.74 Cr | ₹1.82 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MERCURY LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹1.89 Cr |
Mar2022 | ₹2.23 Cr |
Mar2021 | ₹2.13 Cr |
Mar2020 | ₹1.74 Cr |
Mar2019 | ₹1.82 Cr |
How is Deferred Tax Assets / Liabilities of MERCURY LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹1.89 Cr | -15.16 | |
Mar2022 | ₹2.23 Cr | 4.79 | |
Mar2021 | ₹2.13 Cr | 22.30 | |
Mar2020 | ₹1.74 Cr | -4.50 | |
Mar2019 | ₹1.82 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹120.1 Cr | -5.4% | 6.4% | 25.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,025.0 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,299.0 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
CIPLA | ₹132,316.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,579.0 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,092.0 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -5.4% |
6.4% |
25.9% |
SENSEX | 0.3% |
3% |
23.3% |
You may also like the below Video Courses